Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia.
Alvaro Hernández MartínezPilar Navajas HernándezMaría Del Mar Martín RodríguezMarta Lázaro SáezRaúl Olmedo MartínAndrea Núñez OrtizFederico Argüelles-AriasMaría Carmen Fernández CanoFrancisco Gallardo SánchezSandra Marín PedrosaJavier González GarcíaJuan María Vázquez MorónPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2022)
tofacitinib has a demonstrated efficacy in clinical practice to induce and maintain clinical response in treatment-refractory UC patients, with an acceptable safety profile.